D&D Pharmatech Inc. (KOSDAQ:347850)

South Korea · Delayed Price · Currency is KRW

60,900

-4,800 (-7.31%)

Aug 11, 2026, 3:30 PM KST

D&D Pharmatech Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	3,013	4,298	11,437	18,677	610.57	1,364
Revenue Growth	-71.91%	-62.42%	-38.77%	2958.97%	-55.24%	-
Gross Profit	2,988	4,272	11,417	18,656	579.21	1,338
Operating Income	-35,802	-33,993	-25,017	-13,486	-68,653	-75,677
Net Income	-23,200	-23,555	-28,623	3,934	-136,067	-68,224
Earnings Per Share	-774.30	-771.79	-706.00	110.37	-4220.50	-2173.66
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
China	515.11	515.11	515.11	515.11	515.11
USA	-	3,782	10,922	18,162	95.46
Total	3,013	4,298	11,437	18,677	610.57

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	24,573	32,884	30,014	15,642	25,504	75,958
Total Debt	5,993	6,245	9,782	8,134	27,233	43,575
Net Cash (Debt)	18,580	26,639	20,231	7,508	-1,729	32,383
Net Cash Growth	5.50%	31.67%	169.47%	-	-	-40.99%
Net Cash Per Share	428.55	606.37	498.86	200.09	-53.64	983.80

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-24,899	-21,139	-21,805	-9,117	-53,083	-51,945
Capital Expenditures	-36.59	-64.41	-395.75	-45.22	-711.88	-1,615
Free Cash Flow	-24,935	-21,203	-22,201	-9,163	-53,795	-53,560
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	99.17%	99.41%	99.83%	99.89%	94.86%	98.09%
Operating Margin	-1188.28%	-790.97%	-218.74%	-72.21%	-11244.15%	-5547.71%
Pretax Margin	-841.82%	-579.42%	-265.43%	24.06%	-26780.48%	-5281.64%
Profit Margin	-770.03%	-548.09%	-250.27%	21.06%	-22285.31%	-5001.38%
FCF Margin	-827.62%	-493.38%	-194.12%	-49.06%	-8810.69%	-3926.36%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	926.51	929.95	44.91	-	-	-